Ms. Chiu’s experience includes representing:
- R-Bridge Healthcare Fund in its royalty- and revenue interest-based financing in Trevena, Inc.
- HighTide Therapeutics in its Series C financing
- SK Biopharmaceuticals in its launch of Ignis Therapeutics, a biotech joint venture with 6 Dimensions Capital and other notable investors
- Huadong Medicine in its license agreement with AKSO Biopharmaceutical
- ArriVent Biopharma in its strategic research collaboration with Aarvik Therapeutics
- SoftBank Group Corp. and SoftBank Vision Fund in its sale of Arm Limited to NVIDIA*
- Ascendent Capital Partners on its disposal of Etern Group Ltd. to Hygeia*
- Ascendent Capital Partners, as a consortium member, in the privatization of Tarena International, Inc.*
*Denotes experience prior to joining Goodwin.